Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Philip Morris

The two tobacco giants confirmed that they're in talks about potentially reuniting.

Why Altria Stock Is Smoking Hot Today -- and Philip Morris Isn't

Deal would merge the Marlboro maker with the parent company that sold it off a decade ago

Tobacco companies Philip Morris and Altria in talks to reunite

Altria news for Tuesday includes MO stock heading higher after announcing a possible possible merger with Philip Morris (PMI).
The post Altria News: MO Stock Surges on Philip Morris Merger Buzz appeared first on InvestorPlace.

Altria News: MO Stock Surges on Philip Morris Merger Buzz

Philip Morris International Inc  and Altria Group Inc  are discussing an all-stock merger, potentially reuniting two of the world's largest tobacco companies after more than a decade, in a deal aimed at domination of the fast-growing electronic-cigarette market.

Philip Morris in merger talks with Altria; e-cigs a focus

Altria said Tuesday it was "in discussions" with Philip Morris International to merge once again, sending Altria stock soaring and Philip Morris lower. 

Altria Stock Soars As It Weighs Getting Back Together With Philip Morris

Philip Morris International Inc and Altria Group Inc are in talks for an all-stock merger, potentially reuniting the tobacco giants after more than a decade in a deal aimed at dominating the fast-growing e-cigarette market.

Philip Morris in talks to reunite with Altria

Philip Morris International and Altria Group said on Tuesday they were in talks for an all-stock merger, potentially reuniting the tobacco giants after more than a decade. Altria’s shares rose over 8 percent in early trading, while Philip Morris fell 5.5 percent.

Tobacco giants Philip Morris and Altria may merge

There is a long push-pull effort among investment banking advisory trends in which Wall Street tells corporate America how it should be positioning itself.

Philip Morris International and Altria Want to Get Together All Over Again

Philip Morris International Inc. PM, -6.96% said Tuesday it is in talks with Altria Group Inc.

Philip Morris confirms talks with Altria on a potential merger of equals

Philip Morris International is in discussions with Altria about a possible all-stock, merger of equals, the tobacco giant announced Tuesday.

Philip Morris International confirms it's in merger talks with Altria

Becton, Dickinson and Co.

Lowe's

Income investors can rest easy with these dividend-paying royalty.

3 Dividend Aristocrats - to Buy and Hold Forever.

Ford Motor Company

General Motors

AT&T

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

Exxon Mobil

Falling interest rates will give high-yielding dividend stocks a boost in the coming decade. Here are seven names to buy.

7 High-Yielding Dividend Stocks to Buy for the Next Decade

British American Tobacco

With traditional cigarettes and e-cigs are under attack, snus and tobacco-free nicotine pouches could thrive.

This Under-the-Radar Smoking Alternative Could Be Bigger Than E-Cigs

AbbVie

Occidental Petroleum

Schlumberger

Even though interest rates have plunged back to the levels seen six and seven years ago, the reality is that we are in some of the lowest rate levels in over a generation.

5 Incredible Blue Chip Stocks With 6% or Higher Dividends

The cigarette business isn’t exactly smoking these days. And as investors have moved away from Big Tobacco, lowering share prices, one of the biggest cigarette companies has also broadened its product line beyond traditional cigarettes.

Morgan Stanley Upgrades Altria On Better Price

It almost seems too good to be true that a tobacco giant can keep raising its dividend year in and year out.

Altria Delivers Another Dividend Hike With a Monster Yield

Altria Group Inc. MO, +0.55% said Thursday it will raise its quarterly dividend by 5%, to 84 cents a share from 80 cents.

Altria boosts dividend, to an implied yield of over 7%

E-cigarette maker Juul Labs Inc has raised $325 million in an equity and debt offering to speed up its global expansion as US lawmakers seek to crackdown on the vaping company, which has proven popular with teens. Juul — 35% owned by Marlboro maker Altria Group Inc — has been refocusing its efforts on growing.

Juul raises $325 million for global expansion amid US crackdown

E-cigarette maker Juul Labs Inc has raised $325 million in an equity and debt offering, a regulatory filing showed on Monday, as the company looks to speed up its global expansion at a time it is facing growing U.S. regulatory scrutiny.

Juul raises $325 million in equity and debt financing

The tobacco giant has been dinged for its investment in the e-cig maker as concerns about U.S. regulation grow.

Juul's International Ambitions May Be the Real Value for Altria

Las Vegas Sands

Delayed tariff hikes and the potential for further Federal Reserve interest rate cuts have boosted these four dividend-yielding companies. PM, MO, LVS and F are great stocks to buy now.

4 Big Dividend Stocks to Buy Now

America’s Smoking Demographics are Changing.

Altria Group: Demographics Are Destiny

Coty

General Mills

Kimco Realty

Public Storage

Target

There are currently approximately 136 S&P 500 stocks yielding 3% or more. Here are seven stocks to buy amongst this group of dividend stocks.

7 S&P 500 Dividend Stocks to Buy With Yields of at Least  3%

Cronos Group

I wouldn’t be surprised if the recent $300 million purchase of Los Angeles-based Redwood Holding Group, a manufacturer of hemp-derived cannabidiol (CBD) infused skincare and other hemp-derived products, was an idea hatched by Altria. 
The post Cronos Stock Still Looks Like a Brilliant Investment for Altria appeared first on InvestorPlace.

Cronos Stock Still Looks Like a Brilliant Investment for Altria

Tobacco shares are trading lower after CNBC reported emerged the FDA is investigating 127 reports of seizures after vaping.

News for Altria Stock (MO)